Navigation Links
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

dated Statements of Operations has been

derived from the audited financial statements for the periods

indicated.

Condensed Consolidated Balance Sheet Data

(In thousands)

December 31, December 31,

2007 2006

(Note)

Assets

Cash, cash equivalents and short-term

investments $398,185 $388,825

Accounts receivable 1,901 310

Other current assets 9,162 10,551

Land, property and equipment, net 65,940 56,500

Acquired technology and other non-current assets 12,318 12,279

Total assets $487,506 $468,465

Liabilities and Stockholders' Equity

Accounts payable, accrued expenses and

accrued compensation $30,058 $22,947

Total deferred revenues 4,049 13,054

Total lease financing obligations and other

long-term liabilities 63,100 14,541

Redeemable convertible preferred stock 53,922 51,808

Total stockholders' equity 336,377 366,115

Total liabilities and stockholders' equity $487,506 $468,465

Note: The Condensed Consolidated Balance Sheet Data has been derived from

the audited financial statements as of that date.

Contacts: Jack Lief Mary Claire Duch

President and CEO WeissComm Partners

Media Relations


'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... Investor-Edge has initiated coverage ... GENE ), Agilent Technologies Inc. (NYSE: ... TMO ), Sequenom Inc. (NASDAQ: SQNM ), ... research report on Genetic Technologies can be accessed ... 2015, the NASDAQ Composite ended at 4,941.42, down ...
(Date:5/1/2015)... Md. and RESEARCH TRIANGLE PARK, N.C. ... UTHR ) announced today that Roger Jeffs , ... provide an overview and update on the company,s business at ... in Boston, Massachusetts . The ... 3:30 PM Eastern Time, and can be accessed via a ...
(Date:4/30/2015)... 2015   Tamir Biotechnology , a leading developer ... its Ebola antiviral therapy program. Clinical ... currently being evaluated and considered by a number of ... During the first quarter of 2015, the company participated ... The Evaluation of Potential Treatments and Vaccines For Ebola ...
(Date:4/30/2015)... April 30, 2015 Nitto Avecia, ... announces its increased capacity and production capability to ... client variety and service fulfillment continues to drive ... improve process throughput capacities. , In ... installed downstream process equipment at its Milford, MA ...
Breaking Biology Technology:Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 3Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 4Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 5Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2
... May 13 When Sergeant Heather Maddy of the,325th ... of Nashua, NH inquiring about a desperately needed piece,of ... operating,rooms, she never expected one to be delivered within ... let you know that we received the Doppler [System] ...
... and CLAREMONT, Calif., May 13 /Xinhua-PRNewswire-FirstCall/ --,Kiwa ... KWBT),announced finalization of an agreement establishing a ... anti-viral product., On May 9, General ... (,Huaxing,), Mr. Ruijun Li and his associates ...
... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , ... company, today announced the appointment of Dr. Hank,McKinnell ... is the former Chief Executive Officer and former ... He is currently Chairman of the,Accordia Global Health ...
Cached Biology Technology:Serving Those Who Serve Our Country: Medical Device Company Answers the Call of a U.S. Combat Hospital in Iraq 2Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd. 2Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd. 3Angiotech appoints Hank McKinnell to its Board of Directors 2
(Date:4/2/2015)... , April 2, 2015 ... touch fingerprint sensor FPC1025 from the distributor World Peace ... commence during Q2 2015 although the major part of ... sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of ...
(Date:3/30/2015)... and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) has announced ... in Automotive Sector 2014-2018" report to their offering. ... market in Automotive Sector to grow at a CAGR ... recognition is the ability of a device to identify ... recognition technology can be 2D-based or 3D-based. It uses ...
(Date:3/24/2015)... 24, 2015   Crossmatch ™, a leading ... that its U.are.U ® 4500 Fingerprint Readers ... Bros . to achieve PCI compliance for Point-of-Sale ... to the POS terminal, protecting the retailer and ... breaches. With one-third of worldwide ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... dense profusion of branches, the Tree of Life is ... major strides have been made to establish the evolutionary ... still in its infancy. At Arizona State ... the Tree of Life by developing sophisticated methods and ...
... researchers received a five-year, $5 million grant from the National ... risk profiles of breast cancer survivors likely to suffer from ... which will provide the 300 volunteers needed for the study ... have been treated for breast cancer and don,t have a ...
... in agricultural fields and a contributor to poor water quality ... the P Index was proposed as a risk assessment tool ... pains, does the P Index accurately assess the risk of ... in the Journal of Environmental Quality addresses that ...
Cached Biology News:A new computational method for timing the tree of life 2A new computational method for timing the tree of life 3UCLA researchers to study depression in breast cancer survivors 2UCLA researchers to study depression in breast cancer survivors 3The Phosphorus Index: Changes afoot 2The Phosphorus Index: Changes afoot 3
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
... converts Cap 0 (or Cap 0-like) RNA ... structure has been shown to increase in ... This improvement is seen in Cap 0 ... System as well as those Cap 0 ...
Form: Concentrated Applications: ELISA...
Form: Ready to use Applications: ELISA...
Biology Products: